読み込み中
NYSEHealthcareMedical - Healthcare Information Services
最新データ
$10.81
+$0.15 · +1.41%
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
前日終値
$10.81
+$0.15 · +1.41%
日中の時刻はETです。市場データは遅延する場合があります。
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
日中レンジ
現在 $10.81
52週レンジ
現在 $10.81
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
62
割安
センチメント
60
まちまち
リスク
64
高リスク
モメンタム
32
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
日中レンジ
現在 $10.81
52週レンジ
現在 $10.81
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2026年度 | 2025年度 | 2024年度 | 2023年度 | 2022年度 |
|---|---|---|---|---|---|
| 売上高 | 4.81億 USD | 4.2億 USD | 3.56億 USD | 2.81億 USD | 2.13億 USD |
| 売上原価 | 1.54億 USD | 1.35億 USD | 1.24億 USD | 1.09億 USD | 8138.8万 USD |
| 粗利益 | 3.26億 USD | 2.85億 USD | 2.32億 USD | 1.72億 USD | 1.32億 USD |
| 研究開発 | 1.21億 USD | 1.17億 USD | 1.12億 USD | 9124.4万 USD | 5226.5万 USD |
| 販売・一般管理 | 1.8億 USD | 1.98億 USD | 2.27億 USD | 2.32億 USD | 1.75億 USD |
| 営業費用 | 3.33億 USD | 3.43億 USD | 3.69億 USD | 3.48億 USD | 2.49億 USD |
| 受取利息 | 217.3万 USD | 267.7万 USD | 406.5万 USD | 247.5万 USD | 7.9万 USD |
| 支払利息 | 695.3万 USD | 234.7万 USD | 185.4万 USD | 141.1万 USD | 116.3万 USD |
| 減価償却費と償却費 | 3145.3万 USD | 2788.6万 USD | 2948.7万 USD | 2530.4万 USD | 2451.7万 USD |
| 営業利益 | −661.2万 USD | −5809.7万 USD | −1.36億 USD | −1.77億 USD | −1.17億 USD |
| 純利益 | 230.6万 USD | −5852.7万 USD | −1.37億 USD | −1.76億 USD | −1.18億 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$12.00
上昇余地（11.01%）この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI2242.78万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM1439.64万0.02%787.4億 USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF823.29万0.01%954億 USD0.05%$235+0.80%
Fidelity Enhanced Small Cap ETFFESM548.29万0.08%64.1億 USD0.28%$45.46+0.46%
iShares Russell 2000 Growth ETFIWO423.76万0.03%139.17億 USD0.24%$356.78+0.94%
Vanguard Russell 2000 ETFVTWO348.66万0.02%180億 USD0.06%$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA278.95万0.01%218.24億 USD0.03%$32.79+0.40%
Principal U.S. Small-Cap Multi-Factor ETFPSC245.05万0.09%27億 USD0.38%$67.70+0.61%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFFidelity Enhanced Small Cap ETFFESMiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAPrincipal U.S. Small-Cap Multi-Factor ETFPSCAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
